Area of research
Cardiology and Cardiovascular Medicine · Epidemiology
Research interest
Research interests include Cardiovascular Disease and Adiposity, Liver Disease Diagnosis and Treatment, Cardiovascular Function and Risk Factors, and Cardiac Imaging and Diagnostics.
Loss of Hepatocyte FOXA3 Improves MASH and Atherosclerosis in Hyperlipidemic Ldlr-Deficient Mice.
Neprilysin in Placental EVs as Culprits and Therapeutic Target for Preeclampsia.
Mouse Model of Coronary Collateral Growth Through Repetitive Ischemia.
Exosomal NAMPT from Engineered Mesenchymal Stem Cells Mitigates Aortic Stenosis via Metabolic and Anti-Inflammatory Pathways.
Does coronary microvascular dysfunction play a role in heart failure with reduced ejection fraction?
The fatty acid omega hydroxylase genes (CYP4 family) in the progression of metabolic dysfunction-associated steatotic liver disease (MASLD): An RNA sequence database analysis and review.
Krüppel-like factor 10 protects against metabolic dysfunction-associated steatohepatitis by regulating HNF4α-mediated metabolic pathways.
Hepatic FOXA3 overexpression prevents Western diet-induced obesity and MASH through TGR5.
Bone marrow cells contribute to seven different endothelial cell populations in the heart.
Takotsubo syndrome is a coronary microvascular disease: experimental evidence.
Is miR-21 A Therapeutic Target in Cardiovascular Disease?
Hepatocyte Sirtuin 6 Protects against Atherosclerosis and Steatohepatitis by Regulating Lipid Homeostasis.
The Roles of Bone Marrow-Derived Stem Cells in Coronary Collateral Growth Induced by Repetitive Ischemia.
Editorial: Women in cardiovascular therapeutics.
Mechanism of the switch from NO to H<sub>2</sub>O<sub>2</sub> in endothelium-dependent vasodilation in diabetes.
Mitochondrial DNA integrity and function are critical for endothelium-dependent vasodilation in rats with metabolic syndrome.
The essential role for endothelial cell sprouting in coronary collateral growth.
Role of endothelial CXCR4 in the development of aortic valve stenosis.
Hepatocyte Nuclear Factor 4α Prevents the Steatosis-to-NASH Progression by Regulating p53 and Bile Acid Signaling (in mice).
Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism.
Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease.
Endothelial TRPV4 channels prevent tumor growth and metastasis via modulation of tumor angiogenesis and vascular integrity.
Hepatocytic Activating Transcription Factor 3 Protects Against Steatohepatitis via Hepatocyte Nuclear Factor 4α.
Hepatocyte-specific expression of human carboxylesterase 2 attenuates nonalcoholic steatohepatitis in mice.
The role of MSC derived exosomes on cardiac microvascular dysfunction.
Macrophage miR-34a Is a Key Regulator of Cholesterol Efflux and Atherosclerosis.
Hepatocyte-Specific Expression of Human Carboxylesterase 1 Attenuates Diet-Induced Steatohepatitis and Hyperlipidemia in Mice.
Step by Step: Advancing the Understanding of Local Vascular Control.
Macrophage miR-34a Is a Key Regulator of Cholesterol Efflux and Atherosclerosis
Cardioprotection during ischemia by coronary collateral growth.